Discovery could lead to more effective PARP inhibitor drugs against cancer
Penn researchers find that an enzyme that reduces the effects of PARP inhibition could be targeted to achieve more potent killing of cancer cells and overcome tumors’ resistance to this class of drugs.
FULL STORY AT Penn Medicine News →